Fresenius SE KGaAXTER:FRE +0.43%67 Median PS Value is €31.92 as of Jun. 24, 2026, which is 100% below its 10-year median of 0.77. GuruFocus rates XTER:FRE with a GF Score™ of 67/100 and a GF Value™ of €36.55 (Fairly Valued). The stock has 5 warning signs investors should review. Among 264 Healthcare Providers & Services companies, Fresenius SE KGaA ranks worse than 85.23% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Fresenius SE KGaA's Median PS Value or its related term are showing as below:
XTER:FRE'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.4 Med: 0.77 Max: 1.54
Current: 1.26
During the past 13 years, the highest Price to Median PS Value of Fresenius SE KGaA was 1.54. The lowest was 0.40. And the median was 0.77.
XTER:FRE's Price-to-Median-PS-Value is ranked worse than 85.23% of 264
companies
in the Healthcare Providers & Services industry
Industry Median: 0.71
vs XTER:FRE: 1.26
Fresenius SE KGaA (XTER:FRE) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Fresenius SE KGaA's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
40.07
/
31.92
=
1.26
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius SE KGaA Median PS Value Related Terms
Fresenius SE KGaA Median PS Value Historical Data
* Premium members only.
The historical data trend for Fresenius SE KGaA's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:FRE vs HCA, THC, DVA: Median PS Value Comparison
For the Medical Care Facilities subindustry, Fresenius SE KGaA's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius SE KGaA Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Fresenius SE KGaA's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.7794.
Fresenius SE KGaA's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €40.955.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius SE KGaA (XTER:FRE) has a Median PS Value of €31.92 as of Jun. 24, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Fresenius SE KGaA and its competitors. This is 4045% above median its historical median of 0.77. Over the past decade, Fresenius SE KGaA's Median PS Value has ranged from 0.40 to 1.54. According to the industry distribution chart, Fresenius SE KGaA ranks #225 out of 264 companies in the Healthcare Providers & Services industry, placing it in the top 85.2%.
Is Fresenius SE KGaA's Median PS Value too high?
Fresenius SE KGaA's current Median PS Value of €31.92 is 4045% above median its 10-year median of 0.77. Over the past 10 years, this metric has ranged from a low of 0.40 to a high of 1.54. Based on the distribution chart, Fresenius SE KGaA ranks #225 out of 264 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Fresenius SE KGaA has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Median PS Value compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #225 out of 264 companies for Median PS Value. This places Fresenius SE KGaA in the lower half of its industry. The industry median Median PS Value is 0.71. Historically, Fresenius SE KGaA's own Median PS Value has ranged from 0.40 to 1.54 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.71, based on 264 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Fresenius SE KGaA and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius SE KGaA's current Median PS Value is €31.92, which is 4045% above median its own 10-year median of 0.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XTER:FRE) is currently considered Fairly Valued. The stock's GF Value™ is €36.55, compared to a current price of €40.07 — trading 9.6% above its estimated fair value. The current Median PS Value is €31.92, which is 4045% above median its 10-year median of 0.77. Fresenius SE KGaA's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Fresenius SE KGaA (XTER:FRE), the current Median PS Value is €31.92 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius SE KGaA (XTER:FRE) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued.
The current stock price of €40.07 is trading 9.6% above its estimated GF Value™ of €36.55.
GuruFocus considers Fresenius SE KGaA to be Fairly Valued.
Key valuation signals for XTER:FRE:
Median PS Value: €31.92 (4045% above median its 10-year median of 0.77)
GF Value™: €36.55 vs. price of €40.07 (9.6% above fair value)
No single metric tells the full story. See the XTER:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
67GF Score
Get the complete analysis for XTER:FRE
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:FRE has been successfully added to your 
